Massachusetts General Hospital
Clinical trials sponsored by Massachusetts General Hospital, explained in plain language.
-
Vitamin D3 as a Gut-Soothing sidekick for IBD patients?
Disease control TerminatedThis study tests whether adding high-dose vitamin D3 to standard anti-TNF therapy can improve symptoms and reduce inflammation in people with active Crohn's disease or ulcerative colitis. About 100 adults starting anti-TNF treatment will receive either vitamin D3 or a placebo for…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 03, 2026 12:03 UTC
-
Promising cancer combo study pulled before it even started
Disease control TerminatedThis study aimed to see if adding two immune-boosting drugs (zimberelimab and domvanalimab) to standard chemotherapy could help people with operable stomach or esophageal cancer. All participants would have received the treatment before and after surgery, then be followed for up …
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC
-
New drug cocktail shows promise for Tough-to-Treat breast cancer
Disease control OngoingThis study tests a combination of two drugs—sacituzumab govitecan and talazoparib—in people with metastatic triple-negative breast cancer that has spread. The goal is to see if the pair can shrink tumors and slow the disease. About 75 adults with this aggressive cancer type are t…
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC
-
New drug trial aims to ease long COVID symptoms in kids and adults
Disease control OngoingThis study tests whether the drug larazotide can safely reduce Long COVID symptoms in people aged 7 to 50. Participants take the drug or a placebo four times daily for 21 days. The goal is to see if symptoms like fatigue, brain fog, and breathing problems improve. The trial is no…
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 02, 2026 11:59 UTC
-
Peanut allergy breakthrough: daily doses could build tolerance
Disease control OngoingThis study looks at whether a treatment called oral immunotherapy (OIT) can help people with peanut allergy safely eat small amounts of peanut protein without having an allergic reaction. About 500 people aged 6 months to 65 years will gradually increase their peanut intake under…
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 02, 2026 11:58 UTC
-
New study aims to ease the load for parents of kids with tracheostomies
Symptom relief ENROLLING_BY_INVITATIONThis study looks at how to best support parents and caregivers who take care of a child with a tracheostomy at home. About 480 caregivers will be randomly assigned to receive either a standard discharge program or that program plus extra support. Researchers will measure caregive…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 03, 2026 12:02 UTC
-
Brain scans reveal TMS's inner workings in depression
Knowledge-focused OngoingThis study looks at how transcranial magnetic stimulation (TMS) affects brain connections in people with major depression. About 54 adults who are already scheduled for TMS treatment will have MRI scans before and after therapy. The goal is to understand the brain changes behind …
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 04, 2026 11:02 UTC
-
New camera tech could spot gut disease without cutting tissue
Knowledge-focused ENROLLING_BY_INVITATIONThis study is testing new optical imaging tools that can look at gut tissue samples without destroying them. Researchers want to see if these images can help detect diseases like those affecting the stomach or intestines. About 200 people scheduled for a routine upper endoscopy o…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 02, 2026 11:59 UTC